128 related articles for article (PubMed ID: 9553992)
1. Excitatory amino acid antagonists alleviate convulsive and toxic properties of lindane in mice.
Blaszczak P; Turski WA
Pharmacol Toxicol; 1998 Mar; 82(3):137-41. PubMed ID: 9553992
[TBL] [Abstract][Full Text] [Related]
2. Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice.
De Sarro G; Ammendola D; Nava F; De Sarro A
Brain Res; 1995 Feb; 671(1):131-40. PubMed ID: 7728525
[TBL] [Abstract][Full Text] [Related]
3. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182
[TBL] [Abstract][Full Text] [Related]
4. Lindane-induced convulsions in NMRI and OF1 mice: antagonism with (+)MK-801 and voltage-dependent calcium channel blockers.
Tusell JM; Vendrell M; Serratosa J; Trullas R
Brain Res; 1992 Oct; 593(2):209-14. PubMed ID: 1280523
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Pharmacol Biochem Behav; 1996 Oct; 55(2):281-7. PubMed ID: 8951966
[TBL] [Abstract][Full Text] [Related]
6. Effects of AMPA/kainate glutamate receptor antagonists on cocaine-induced convulsions and lethality in mice.
Pouw B; Nour M; Matsumoto RR
Eur J Pharmacol; 1999 Dec; 386(2-3):181-6. PubMed ID: 10618468
[TBL] [Abstract][Full Text] [Related]
7. AMPA/kainate-related mechanisms contribute to convulsant and proconvulsant effects of 3-nitropropionic acid.
Urbanska EM; Blaszczak P; Saran T; Kleinrok Z; Turski WA
Eur J Pharmacol; 1999 Apr; 370(3):251-6. PubMed ID: 10334499
[TBL] [Abstract][Full Text] [Related]
8. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
9. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
10. Excitatory amino acid antagonists protect mice against seizures induced by bicuculline.
Turski WA; Urbanska E; Dziki M; Parada-Turska J; Ikonomidou C
Brain Res; 1990 Apr; 514(1):131-4. PubMed ID: 2162707
[TBL] [Abstract][Full Text] [Related]
11. Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA/2 mice.
De Sarro G; Renne S; Nava F; De Sarro A
J Pharm Pharmacol; 1994 Dec; 46(12):1017-22. PubMed ID: 7714713
[TBL] [Abstract][Full Text] [Related]
12. N6-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice.
Assi AA
J Pharm Pharm Sci; 2001; 4(1):42-51. PubMed ID: 11302789
[TBL] [Abstract][Full Text] [Related]
13. NMDA and not non-NMDA receptor antagonists are protective against seizures induced by homocysteine in neonatal rats.
Folbergrová J
Exp Neurol; 1994 Dec; 130(2):344-50. PubMed ID: 7867764
[TBL] [Abstract][Full Text] [Related]
14. Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion.
DeGiorgio LA; DeGiorgio N; Volpe BT
Neuroscience; 1999 Apr; 90(1):79-85. PubMed ID: 10188935
[TBL] [Abstract][Full Text] [Related]
15. Reduction of dizocilpine and scopolamine-induced deficits in avoidance responding by SCH 54388, a metabolite of felbamate.
Smith RD; Grzelak ME; Coffin VL
Pharmacol Biochem Behav; 1997 Nov; 58(3):657-64. PubMed ID: 9329055
[TBL] [Abstract][Full Text] [Related]
16. Metabotropic and ionotropic excitatory amino acid receptor agonists induce different behavioral effects in mice.
Laudrup P; Klitgaard H
Eur J Pharmacol; 1993 Nov; 250(1):15-22. PubMed ID: 7509749
[TBL] [Abstract][Full Text] [Related]
17. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
Swedberg MD; Jacobsen P; Honoré T
J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
[TBL] [Abstract][Full Text] [Related]
18. Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia.
Nellgård B; Wieloch T
Exp Brain Res; 1992; 92(2):259-66. PubMed ID: 1362958
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant activity of delta-HCH, calcium channel blockers and calmodulin antagonists in seizures induced by lindane and other convulsant drugs.
Tusell JM; Barrón S; Serratosa J
Brain Res; 1993 Sep; 622(1-2):99-104. PubMed ID: 7694769
[TBL] [Abstract][Full Text] [Related]
20. Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats.
Engber TM; Anderson JJ; Boldry RC; Papa SM; Kuo S; Chase TN
Neuroscience; 1994 Mar; 59(2):389-99. PubMed ID: 8008198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
